Trial Profile
A randomized, double-blind, multi-centre, placebo-controlled, parallel-group study to examine the efficacy and safety of low dose Epoetin beta on wound healing in diabetes patients with foot ulcer.
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 21 Jun 2011
Price :
$35
*
At a glance
- Drugs Epoetin alfa (Primary)
- Indications Diabetic foot ulcer
- Focus Therapeutic Use
- Sponsors EPOPLUS
- 21 Jun 2011 New trial record